Augmenting atypical antipsychotics with a cognitive enhancer (donepezil) improves regional brain activity in schizophrenia patients: a pilot double-blind placebo controlled BOLD fMRI study.

Ziad Nahas; Mark S George; Michael D Horner; John S Markowitz; Xingbao Li; Jeffrey P Lorberbaum; Susan D Owens; Susan McGurk; Lindsay DeVane; S Craig Risch

doi:10.1076/neur.9.3.274.15563

Augmenting atypical antipsychotics with a cognitive enhancer (donepezil) improves regional brain activity in schizophrenia patients: a pilot double-blind placebo controlled BOLD fMRI study.

Identifier:nobleid.org/w1/20260515/CD2CB17B

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CD2CB17B.svg?ark=w1%2F20260515%2FCD2CB17B)](https://nobleid.org/work/w1/20260515/CD2CB17B)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Augmenting atypical antipsychotics with a cognitive enhancer (donepezil) improves regional brain activity in schizophrenia patients: a pilot double-blind placebo controlled BOLD fMRI study.

Identifier:nobleid.org/w1/20260515/CD2CB17B

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CD2CB17B.svg?ark=w1%2F20260515%2FCD2CB17B)](https://nobleid.org/work/w1/20260515/CD2CB17B)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work